Showing results (131-140 of 272) with videos related to

Sort By:
Pageof 28
Diabetes|November 1, 1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDMC Saloranta, M R Taskinen, E Widen, et al.
Diabetologia|January 11, 2001
Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic stateD Tripathy, A L Carlsson, M Lehto, et al.
Diabetologia|April 6, 2002
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cellsJ Hoffstedt, M Rydén, P Löfgren, et al.
Diabetologia|September 27, 2012
Effect of a common variant of the PCSK2 gene on reduced insulin secretionA Jonsson, B Isomaa, T Tuomi, et al.
The American Journal of Medicine|August 1, 1989
Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapyL Groop, C Schalin, A Franssila-Kallunki, et al.
Diabetologia|October 13, 2001
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetesB Isomaa, M Henricsson, P Almgren, et al.
Diabetes Research and Clinical Practice|May 19, 2009
Evaluation of the effects of exercise on insulin sensitivity in Arabian and Swedish women with type 2 diabetesF Glans, K-F Eriksson, A Segerström, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 11, 2012
INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathyM E Hyvönen, P Ihalmo, C Forsblom, et al.
Diabetologia|August 18, 2012
HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetesJ Söderlund, C Forsblom, J Ilonen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 1999
The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research TeamL Landstedt-Hallin, P Arner, P E Lins, et al.
Pageof 28